Zeo ScientifiXZEOX +10.82%56 Net Debt Paydown Yield % is 1.53% as of Jul. 12, 2026. GuruFocus rates ZEOX with a GF Score™ of 56/100 and a GF Value™ of $2.66 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,160 Biotechnology companies, Zeo ScientifiX ranks better than 78.02% on this metric.
Net Debt Paydown Yield % is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. It is a measure of a company's willingness and ability to reduce its debt.
As of today, Zeo ScientifiX's Net Debt Paydown Yield % was 1.53%.
Zeo ScientifiX (OTCPK:ZEOX) Net Debt Paydown Yield % Explanation
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced. In other words, it is a measure of the willingness and ability of a firm's management to pay down debt. Companies that have high debt paydown yields indicate that they are more aggressive with paying down debt.
In the calculation of Net Debt Paydown Yield %, we use the reductions of TTM average total debt one-year-ago and TTM average total debt at present, divided by its Market Cap.
Zeo ScientifiX Net Debt Paydown Yield % Related Terms
Zeo ScientifiX Net Debt Paydown Yield % Historical Data
* Premium members only.
The historical data trend for Zeo ScientifiX's Net Debt Paydown Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ZEOX vs JUNS, HOOK, LEXX: Net Debt Paydown Yield % Comparison
For the Biotechnology subindustry, Zeo ScientifiX's Net Debt Paydown Yield %, along with its competitors' market caps and Net Debt Paydown Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zeo ScientifiX Net Debt Paydown Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zeo ScientifiX's Net Debt Paydown Yield % distribution charts can be found below:
* The bar in red indicates where Zeo ScientifiX's Net Debt Paydown Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Net Debt Paydown Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
What does a Net Debt Paydown Yield % of 1.53% mean?
Zeo ScientifiX (ZEOX) has a Net Debt Paydown Yield % of 1.53% as of Jul. 12, 2026. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Zeo ScientifiX and its competitors. According to the industry distribution chart, Zeo ScientifiX ranks #255 out of 1160 companies in the Biotechnology industry, placing it in the top 22%.
Is Zeo ScientifiX's Net Debt Paydown Yield % too high?
Zeo ScientifiX's current Net Debt Paydown Yield % is 1.53%. The Biotechnology industry median Net Debt Paydown Yield % is 0.04. Zeo ScientifiX's value of 1.53% is 4271.4% above this industry median. Based on the distribution chart, Zeo ScientifiX ranks #255 out of 1160 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Zeo ScientifiX has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zeo ScientifiX's Net Debt Paydown Yield % compare to JUNS and HOOK?
According to the Biotechnology industry distribution chart, Zeo ScientifiX ranks #255 out of 1160 companies for Net Debt Paydown Yield %. This places Zeo ScientifiX in the top 22% of its industry — outperforming the majority of peers. The industry median Net Debt Paydown Yield % is 0.04. Zeo ScientifiX's value of 1.53% is 4271.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Debt Paydown Yield % for a Biotechnology company?
The median Net Debt Paydown Yield % among Biotechnology companies is 0.04, based on 1,160 companies in the industry. Companies in the top quartile (top 25%) have a Net Debt Paydown Yield % significantly above this median, while those in the bottom quartile fall well below. However, Net Debt Paydown Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zeo ScientifiX's current Net Debt Paydown Yield % of 1.53% is 4271.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Debt Paydown Yield % mean?
A high Net Debt Paydown Yield % can signal that a stock is expensive relative to its fundamentals. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Zeo ScientifiX and its competitors. For the Biotechnology industry, the median Net Debt Paydown Yield % is 0.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zeo ScientifiX's current Net Debt Paydown Yield % is 1.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zeo ScientifiX stock overvalued right now?
Based on GuruFocus' analysis, Zeo ScientifiX (ZEOX) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.66, compared to a current price of $2.10 — trading 21.1% below its estimated fair value. The current Net Debt Paydown Yield % is 1.53% and 4271.4% above the Biotechnology industry median of 0.04. Zeo ScientifiX's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Debt Paydown Yield % calculated?
Net Debt Paydown Yield % is calculated from a company's financial statements. For Zeo ScientifiX (ZEOX), the current Net Debt Paydown Yield % is 1.53% as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zeo ScientifiX (ZEOX) Overvalued in 2026?
Based on GuruFocus' analysis, Zeo ScientifiX stock appears to be undervalued.
The current stock price of $2.10 is trading 21.1% below its estimated GF Value™ of $2.66.
GuruFocus considers Zeo ScientifiX to be Modestly Undervalued.
Key valuation signals for ZEOX:
Net Debt Paydown Yield %: 1.53%
GF Value™: $2.66 vs. price of $2.10 (21.1% below fair value)
Industry Position: 4271.4% above the Biotechnology median (#255 of 1160)
No single metric tells the full story. See the ZEOX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).
56GF Score
Get the complete analysis for ZEOX
Net Debt Paydown Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZEOX has been successfully added to your 
